ANL 12.54 Decreased By ▼ -1.01 (-7.45%)
ASC 12.70 Decreased By ▼ -0.62 (-4.65%)
ASL 13.46 Decreased By ▼ -0.56 (-3.99%)
BOP 8.38 Increased By ▲ 0.02 (0.24%)
BYCO 5.96 Decreased By ▼ -0.18 (-2.93%)
FCCL 17.08 Decreased By ▼ -0.53 (-3.01%)
FFBL 24.05 Decreased By ▼ -0.85 (-3.41%)
FFL 9.97 Decreased By ▼ -0.28 (-2.73%)
FNEL 9.25 Decreased By ▼ -0.55 (-5.61%)
GGGL 14.00 Decreased By ▼ -1.30 (-8.5%)
GGL 27.05 Decreased By ▼ -2.45 (-8.31%)
HUMNL 5.73 Decreased By ▼ -0.17 (-2.88%)
JSCL 15.00 Decreased By ▼ -1.00 (-6.25%)
KAPCO 31.60 Decreased By ▼ -0.45 (-1.4%)
KEL 3.22 Increased By ▲ 0.05 (1.58%)
MDTL 2.09 Decreased By ▼ -0.12 (-5.43%)
MLCF 32.75 Decreased By ▼ -1.64 (-4.77%)
NETSOL 90.21 Decreased By ▼ -5.29 (-5.54%)
PACE 4.10 Decreased By ▼ -0.15 (-3.53%)
PAEL 20.51 Decreased By ▼ -0.92 (-4.29%)
PIBTL 7.25 Decreased By ▼ -0.35 (-4.61%)
POWER 6.39 Decreased By ▼ -0.21 (-3.18%)
PRL 11.95 Decreased By ▼ -0.74 (-5.83%)
PTC 8.80 Increased By ▲ 0.05 (0.57%)
SILK 1.17 Decreased By ▼ -0.08 (-6.4%)
SNGP 37.70 Decreased By ▼ -0.98 (-2.53%)
TELE 14.85 Decreased By ▼ -1.03 (-6.49%)
TRG 77.68 Decreased By ▼ -4.05 (-4.96%)
UNITY 22.90 Decreased By ▼ -0.80 (-3.38%)
WTL 2.03 Decreased By ▼ -0.02 (-0.98%)
BR100 4,381 Decreased By ▼ -20.35 (-0.46%)
BR30 16,863 Decreased By ▼ -630.48 (-3.6%)
KSE100 43,233 Decreased By ▼ -1.32 (-0%)
KSE30 16,718 Increased By ▲ 20.28 (0.12%)

Coronavirus
LOW Source: covid.gov.pk
Pakistan Deaths
28,761
824hr
Pakistan Cases
1,286,453
43124hr
0.98% positivity
Sindh
476,494
Punjab
443,379
Balochistan
33,491
Islamabad
107,848
KPK
180,254

NEW DELHI: India is not considering authorising booster COVID-19 doses yet as many in the country have been naturally infected and the government believes two doses of a vaccine offers sufficient protection for now, three sources with knowledge of the matter said.

As vaccine supplies have increased, some doctors and public health experts in India have urged the government to start a booster programme for the most vulnerable like many Western nations have done.

But authorities will instead concentrate on having most of India's 944 million adults complete a two-dose vaccination by January before shifting their focus to a big expansion in exports, said the sources who are involved in vaccine-policy discussions.

So far, 81% of India's adults have received at least one dose while 43% have had two doses. Vaccination for people under 18 has not yet begun.

Coronavirus toll at 1100 GMT Sunday

"The priority is to fully immunise the adult population," said one of the sources. The sources declined to be named as the matter was still being discussed by policy makers.

"A big majority has been naturally infected, and for them two doses are enough. That's why we are seeing that even after recent festivals, cases are not rising."

The source said that once most adults have had two vaccine doses, the government could make boosters optional.

The health ministry did not respond to a request for comment.

India reported the most COVID-19 case and death figures in the world in April and May and government surveys have shown that nearly 70% of Indians were naturally infected by July.

The country has so far logged 34.5 million infections - the most after the United States - with more than 465,000 deaths.

Although India celebrated two of its biggest festivals, Diwali and Durga Puja in October and November, infections have fallen to multi-month lows.

Many Western countries are expanding their booster programmes, even for people without compromised immunity - a policy which the World Health Organization has heavily criticised.

Indian vaccine companies like the Serum Institute of India, which produces licensed versions of the AstraZeneca and Novavax shots, expect the government to allow boosters some time early next year.

Dr. Reddy's Laboratories says it is in talks with India's drug regulator to sell Russia's Sputnik Light as a booster dose.

Indian states had more than 216 million vaccine doses in stock as of early Monday. India's vaccine output has more than tripled since April to around 300 million doses a month.

We love hearing your feedback, please help us improve by answering these few survey questions

Comments

Comments are closed.